This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
RABBIT ANTI CD268 / BAFF-R
catalog :
AHP2278
quantity :
50 µg
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
mouse
application :
western blot
product information
Entity Category :
Antibodies
Product Code :
AHP2278
Description :
RABBIT ANTI CD268 / BAFF-R
Specificity :
CD268 / BAFF-R
Target Species :
Mouse
Host :
Rabbit
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
WB
Application Types :
Western Blotting
Cross Reactivities :
Human, Rat
Quantity :
50 µg
Quantity Value :
50 µg
Quantity Type :
µg
GO Accessions :
GO:0001782, GO:0002636, GO:0016021, GO:0004872, GO:0009897, GO:0030890, GO:0031295, GO:0031296, GO:0042102, GO:0045078
GO Terms :
activation of B cell proliferation, activation of germinal center formation, activation of interferon-gamma biosynthetic process, activation of T cell proliferation, B cell co-stimulation, B lymphocyte costimulation, B lymphocyte co-stimulation, B lymphocyte homeostasis, B-cell costimulation, B-cell co-stimulation, B-cell homeostasis, B-lymphocyte costimulation, B-lymphocyte co-stimulation, B-lymphocyte homeostasis, GO:0019041, juxtamembrane, outer surface of cytoplasmic membrane, positive regulation of B lymphocyte proliferation, positive regulation of B-cell proliferation, positive regulation of B-lymphocyte proliferation, positive regulation of interferon-gamma anabolism, positive regulation of interferon-gamma biosynthesis, positive regulation of interferon-gamma formation, positive regulation of interferon-gamma synthesis, positive regulation of T lymphocyte proliferation, positive regulation of T-lymphocyte proliferation, receptor guanylate cyclase activity, stimulation of B cell proliferation, stimulation of germinal center formation, stimulation of interferon-gamma biosynthetic process, stimulation of T cell proliferation, T cell co-stimulation, T lymphocyte costimulation, T-cell costimulation, T-cell co-stimulation, T-lymphocyte costimulation, transmembrane, up regulation of B cell proliferation, up regulation of germinal center formation, up regulation of interferon-gamma biosynthetic process, up regulation of T cell proliferation, upregulation of B cell proliferation, up-regulation of B cell proliferation, upregulation of germinal center formation, up-regulation of germinal center formation, up-regulation of interferon-gamma biosynthetic process, upregulation of interferon-gamma biosynthetic process, upregulation of T cell proliferation, up-regulation of T cell proliferation, viral antireceptor activity
Uniprot Accessions :
Q9D8D0
Gene :
Tnfrsf13c
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=72049
EntityFormats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 0.5 mg/ml
Product Form :
Purified IgG - liquid
PrimarySecondary :
Primary
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.